Corteva, Inc. is a leading global provider of seed and crop protection solutions focused on the agriculture industry. The company's business is focused on progressing science-based innovations, which aim to deliver a wide range of improved agriculture products and services to its customers. Corteva's broad portfolio of agriculture solutions fuels farmer productivity in approximately 125 countries. The company operates through two reportable segments: seed and crop protection. The seed segment develops and supplies commercial seed. The crop protection segment supplies products to protect crop yields against weeds, insects and disease.

• Employees: Approximately 22,500 (as of December 31, 2023)
• Geographic Footprint: Approximately 125 countries
• Headquarters: Indianapolis, Indiana
• Founded: March 2018
• Number of locations/facilities: 99 manufacturing sites
• Revenue: $17.23 billion (FY2023)
• Key Subsidiaries/Brands: Pioneer, Brevant, Dairyland Seed, Hoegemeyer, Nutech, Seed Consultants, AgVenture, Cordius, PhytoGen, Pannar

• CEO: Charles V. Magro
• CFO: David J. Anderson
• Executive Vice President, Seed Business Unit: Timothy P. Glenn
• Executive Vice President, Crop Protection Business Unit: Robert King
• Executive Vice President, Chief Technology and Digital Officer: Samuel Eathington
• Senior Vice President, General Counsel and Secretary: Cornel B. Fuerer
• Senior Vice President and Chief Human Resources and Diversity Officer: Audrey Grimm
• Vice President, Controller and Principal Accounting Officer: Brian Titus

The company's chief executive officer and business presidents have an average of approximately 25 years of agriculture experience.

• Annual Revenue: $17.23 billion (FY2023)
• Net Income: $735 million (FY2023) attributable to Corteva
• Total Assets: $43.00 billion (as of December 31, 2023)
• Employees: Approximately 22,500 (as of December 31, 2023)
• Key Financial Highlights: The company reported a 1 percent decrease in net sales versus the year ended December 31, 2022, reflecting a 10 percent decrease in volume and a 1 percent unfavorable impact from currency, partially offset by a 7 percent price increase and a 3 percent favorable portfolio and other impact.

Corteva offers a broad range of products and services across its two segments:

• Seed: Commercial seed combining superior germplasm with advanced traits, including corn, soybeans, sunflower, and cotton seeds. Offers trait technologies that improve resistance to weather, disease, insects and enhance food and nutritional characteristics.
• Crop Protection: Products that protect crop yields against weeds, insects and disease, including herbicides, insecticides, nitrogen stabilizers, pasture and range management herbicides and biologicals.

The company's operations are managed through two reportable segments:

• Seed: Develops and supplies commercial seed, combining superior germplasm with advanced traits.
• Crop Protection: Supplies products to protect crop yields against weeds, insects and disease.

Corteva's strategic priorities include:

• Accelerating performance and growth through a value creation network focused on portfolio simplification, moving towards royalty neutrality, improving product mix, and operational improvements.
• Increasing investment in its industry-leading innovation pipeline focused on delivering more differentiated and sustainably advantaged solutions.
• Deploying capital with discipline by balancing investment, growth, M&A opportunities and returning cash to shareholders.

Corteva competes with producers of seed germplasm, trait developers, and crop protection products on a global basis. The global market is highly competitive and the company believes competition has and will continue to intensify. The company's key competitors include BASF, Bayer, FMC, Syngenta and ChemChina, as well as companies trading in generic crop protection chemicals and regional seed companies.

• Regulatory Risks: The company may not be able to obtain or maintain the necessary regulatory approvals for some of its products, which could restrict its ability to sell those products in some markets.
• Product Development Risks: The successful development and commercialization of Corteva's pipeline products will be necessary for Corteva's growth. New product concepts may be abandoned for many reasons, including greater anticipated development costs, technical difficulties, lack of efficacy, regulatory obstacles or inability to market under regulatory frameworks, competition, inability to prove the original concept, lack of demand and the need to divert focus, from time to time, to other initiatives with perceived opportunities for better returns.
• Public Acceptance Risks: The degree of public understanding and acceptance or perceived public acceptance of Corteva's biotechnology and other agricultural products and technologies can affect Corteva's sales and results of operations by affecting planting approvals, regulatory requirements and customer purchase decisions.
• Competition: Corteva participates in an industry that is highly competitive and has undergone consolidation, which could increase competitive pressures. Corteva currently faces significant competition in the markets in which it operates. In most segments of the market, the number of products available to the grower is steadily increasing as new products are introduced.
• Operational Risks: Corteva is dependent on its relationships or contracts with third parties with respect to certain of its raw materials or licenses and commercialization. Volatility in Corteva's input costs, which include raw materials and production costs, could have a significant impact on Corteva's business, results of operations and financial condition.